Trial offers hope of a breakthrough in treatment for Parkinson’s disease

Clinical trial results offer hope of a potential Parkinson’s disease breakthrough (Jeff Moore/PA)

A former diabetes trial drug could be used to treat Parkinson’s disease within years, research suggests.

The drug, which was designed to treat dyskinesia – involuntary movements that are a common side effect in Parkinson’s patients who take levodopa-based medication for several years – could also improve motor symptoms linked to the condition.